β-catenin-independent noncanonical Wnt pathway might be induced in gastric cancers

Turkish Journal of Gastroenterology

Volumn 21, Issue 3, 2010, Pages 224-230

  Gencer, Salih ^a   Şen, Gürkan ^a   Doǧusoy, Gülen ^b   Belli, Ahmet Korkut ^b   Paksoy, Melih ^b   Yazicioǧlu, M Burcu Irmak ^c  

^a FATIH UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c HALIC UNIVERSITY   (Turkey)

Author keywords

catenin; Gastric cancer; Noncanonical pathway; RT PCR; Wnt signaling

Indexed keywords

BETA CATENIN; MATRILYSIN; MESSENGER RNA; WNT5A PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS;

BETA CATENIN; HUMANS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; WNT PROTEINS;

EID: 77957681425     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0092     Document Type: Article

References (29)

1. Funayama N, Fagotto F, McCrea P, Gumbiner BM. Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J Cell Biol 1995; 128: 959-68.
2. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997; 11: 3286-305. (Pubitemid 28023954)
3. Willert K, Nusse R. Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998; 8: 95-102. (Pubitemid 28122147)
4. Arias AM, Brown AM, Brennan K. Wnt signalling: pathway or network? Curr Opin Genet Dev 1999; 9: 447-54.
5. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51.
6. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12. (Pubitemid 28425575)
7. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-7. (Pubitemid 29234650)
8. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6. (Pubitemid 29180374)
9. Crawford HC, Fingleton BM, Rudolph-Owen LA, et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999; 18: 2883-91.
10. Koh TJ, Bulitta CJ, Fleming JV, et al. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Invest 2000; 106: 533-9.
11. Kolligs FT, Nieman MT, Winer I, et al. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Cancer Cell 2002; 1: 145-55. (Pubitemid 41039161)
12. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 2006; 4: e115.
13. Topol L, Jiang X, Choi H, et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent b-catenin degradation. J Cell Biol 2003; 162: 899-908. (Pubitemid 37087729)
14. Ishitani T, Kishida S, Hyodo-Miura J, et al. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca2+ pathway to antagonize Wnt/b-catenin signaling. Mol Cell Biol 2003; 23: 131-9. (Pubitemid 36008507)
15. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits b-catenin-TCF signaling depending on receptor context. PLoS Biol 2006; 4: 570-82.
16. Olson DJ, Gibo DM. Antisense Wnt-5a mimics Wnt-1-mediated C57MG mammary epithelial cell transformation. Exp Cell Res 1998; 241: 134-41.
17. Liang H, Chen Q, Coles AH, et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell. 2003; 4: 349-60. (Pubitemid 37491096)
18. Kremenevskaja N, von Wasielewski R, Rao AS, et al. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 2005; 24: 2144-54. (Pubitemid 40516581)
19. Dejmek J, Dejmek A, Safholm A, et al. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 2005; 65: 9142-6. (Pubitemid 41507974)
20. Iozzo RV, Eichstetter I, Danielson KG. Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 1995; 55: 3495-9.
21. Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1: 279-88. (Pubitemid 41039152)
22. Pukrop T, Klemm F, Hagemann T, et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA. 2006; 103: 5454-9.
23. Manabu K, Naohide O, Hideki Y, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66: 10439-48.
24. Ohgaki H, Matsukura N. Stomach cancer. Lyon: IARC Press; 2003: 197.
25. Pradeep A, Sharma C, Sathyanarayana P, et al. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene 2004; 23: 3689-99. (Pubitemid 38658436)
26. Kolligs FT, Bommer G, Goke B. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 2002; 66: 131-4.
27. Zuidervaart W, Pavey S, van Nieuwpoort FA, et al. Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Melanoma Res 2007; 17: 380-6.
28. Katoh M. WNT/PCP signaling pathway and human cancer. Oncol Rep 2005; 14: 1583-8.
29. Kenshi M, Keiichi I, Masahiko K, et al. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch 2000; 437: 508-13.